WITHDRAWN: Improved therapeutic effectiveness by combining recombinant p14ARF with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma

Feng Liu; JinTao Du; Junming Xian; Yafeng Liu; Shixi Liu; Yan Lin

doi:10.1016/j.amjoto.2015.01.013

WITHDRAWN: Improved therapeutic effectiveness by combining recombinant p14ARF with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma

Am J Otolaryngol. 2015 Jan 22:S0196-0709(15)00033-2. doi: 10.1016/j.amjoto.2015.01.013. Online ahead of print.

Authors

Feng Liu¹, JinTao Du¹, Junming Xian², Yafeng Liu¹, Shixi Liu¹, Yan Lin³

Affiliations

¹ Department of Otorhinolaryngology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
² Department of Otorhinolaryngology, State Key Laboratory of Biotherapy, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China. Electronic address: [email protected].
³ Department of Otorhinolaryngology, the Second Affiliated Hospital of Kunming Medical College, Kunming, 650101, People's Republic of China.

PMID: 26585064
DOI: 10.1016/j.amjoto.2015.01.013

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.